Related Experiment Video
Updated: Jun 21, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma
Illya Tietzel1, Christelle El-Haibi, Rey A Carabeo
1Department of Natural Sciences, Southern University of New Orleans, New Orleans, LA, USA.
Abstract:
Chlamydiae are obligate intracellular pathogens that are sensitive to pro-inflammatory cytokine interferon-gamma. IFN-gamma-inducible murine p47 GTPases have been demonstrated to function in resistance to chlamydia infection in vivo and in vitro. Because the human genome does not encode IFN-gamma-inducible homologues of these proteins, the significance of the p47 GTPase findings to chlamydia pathogenesis in humans is unclear. Here we report a pair of IFN-gamma-inducible proteins, the human guanylate binding proteins (hGBPs) 1 and 2 that potentiate the anti-chlamydial properties of IFN-gamma. hGBP1 and 2 localize to the inclusion membrane, and their anti-chlamydial functions required the GTPase domain. Alone, hGBP1 or 2 have mild, but statistically significant and reproducible negative effects on the growth of Chlamydia trachomatis, whilst having potent anti-chlamydial activity in conjunction with treatment with a sub-inhibitory concentration of IFN-gamma. Thus, hGBPs appear to potentiate the anti-chlamydial effects of IFN-gamma. Indeed, depletion of hGBP1 and 2 in cells treated with IFN-gamma led to an increase in inclusion size, indicative of better growth. Interestingly, chlamydia species/strains harboring the full-length version of the putative cytotoxin gene, which has been suggested to confer resistance to IFN-gamma was not affected by hGBP overexpression. These findings identify the guanylate binding proteins as potentiators of IFN-gamma inhibition of C. trachomatis growth, and may be the targets of the chlamydial cytotoxin.
Insights
Human guanylate binding proteins (hGBPs) 1 and 2 enhance the anti-chlamydial effects of interferon-gamma (IFN-gamma). These hGBPs potentiate IFN-gamma
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Chlamydiae are obligate intracellular bacteria sensitive to interferon-gamma (IFN-gamma).
- Murine p47 GTPases mediate resistance to chlamydia, but human homologues are unknown, leaving the relevance to human pathogenesis unclear.
Purpose of the Study:
- To identify and characterize human IFN-gamma-inducible proteins that influence chlamydia infection.
- To investigate the role of human guanylate binding proteins (hGBPs) 1 and 2 in potentiating IFN-gamma's anti-chlamydial activity.
Main Methods:
- Localization studies of hGBP1 and hGBP2 within infected cells.
- Assessment of anti-chlamydial activity of hGBPs alone and in combination with IFN-gamma.
- Analysis of chlamydia growth upon depletion of hGBP1 and hGBP2 in IFN-gamma-treated cells.
- Investigation of the effect of hGBP overexpression on chlamydia strains with a specific cytotoxin gene.
Main Results:
- hGBP1 and hGBP2 localize to the chlamydial inclusion membrane and require their GTPase domain for function.
- hGBP1 and hGBP2 exhibit mild but significant anti-chlamydial effects alone, which are potentiated by sub-inhibitory IFN-gamma concentrations.
- Depletion of hGBP1 and hGBP2 reduces IFN-gamma's anti-chlamydial efficacy, leading to increased chlamydia inclusion size.
- Chlamydia strains expressing a full-length cytotoxin gene are unaffected by hGBP overexpression.
Conclusions:
- Human guanylate binding proteins (hGBPs) 1 and 2 are key mediators that potentiate the anti-chlamydial effects of IFN-gamma.
- hGBPs may represent targets of the chlamydial cytotoxin, which confers resistance to IFN-gamma-mediated inhibition.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
GPCRs Regulate Adenylyl Cylase Activity
Two...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

